Clinical forecasting is now leveraging innovative informatics capabilities for more precise recruitment and endpoint projections during a study’s crucial…

Bristol-Myers Squibb

UPDATED: California snares $30M in Bristol-Myers kickbacks case featuring luxury golf, lavish dinners and Lakers camp

Bristol-Myers' Opdivo falls short at NICE, thanks to Pfizer's Inlyta discount

Bristol's Opdivo-Yervoy melanoma combo wins speedy thumbs up from NICE

Merck's Keytruda tops chemo in first-line lung cancer trial

Bristol's Opdivo-Yervoy combo ups response rates in first-line lung cancer patients

UPDATED: BMS joins Amgen in blasting ICER myeloma report

Bristol-Myers' new Opdivo ad touts biomarker advantage over Merck's Keytruda

Roche's Tecentriq bursts onto immuno-oncology scene, with Merck and BMS in its sights

Bristol-Myers has new U.S. biologics capabilities ready to go

BMS' Opdivo gets an FDA OK for Hodgkin's